Bibek Aryal, Yue Yin, Edward A Joseph, David L Bartlett, Sricharan Chalikonda, Casey J Allen
{"title":"Contemporary Nationwide Assessment of Resource Utilization and Perioperative Outcomes in Open and Minimally Invasive Pancreaticoduodenectomy.","authors":"Bibek Aryal, Yue Yin, Edward A Joseph, David L Bartlett, Sricharan Chalikonda, Casey J Allen","doi":"10.1177/00031348241307401","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> While minimally invasive pancreaticoduodenectomy (MIPD) has historically demonstrated benefits over open pancreaticoduodenectomy (OPD), recent advances in perioperative care and surgical techniques may have impacted the relative advantages of these two approaches. This contemporary analysis examines national trends to assess potential differences in resource utilization metrics along with perioperative outcomes between the two approaches. <b>Methods:</b> We analyzed the Nationwide Inpatient Sample database for cancer patients who underwent pancreaticoduodenectomies from 2016 through 2020. We compared socio-demographics, length of stay (LOS), total charges, and perioperative complications between MIPD and OPD. <b>Results:</b> In this observational study, MIPD was associated with lower total charges ($97,470 vs $126,586), shorter LOS (5.05 vs 7.37 days), and lower odds of perioperative complications (OR 1.40, 95% CI 1.18-1.65) compared to OPD. While total charges increased similarly in both groups over time, a declining trend in LOS was observed for OPD (11.49 to 10.36 days). Non-white race and private/other insurance correlated with longer stays, higher charges, and more complications regardless of surgical approach. <b>Conclusions:</b> Despite the gradual improvements in LOS observed with OPD, MIPD demonstrated advantages in resource utilization metrics, indicating potential for reduced healthcare utilization and costs compared to the open surgical approach during the study period. Continued prospective investigation is warranted to comprehensively evaluate MIPD's value proposition.</p>","PeriodicalId":7782,"journal":{"name":"American Surgeon","volume":" ","pages":"31348241307401"},"PeriodicalIF":1.0000,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Surgeon","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00031348241307401","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: While minimally invasive pancreaticoduodenectomy (MIPD) has historically demonstrated benefits over open pancreaticoduodenectomy (OPD), recent advances in perioperative care and surgical techniques may have impacted the relative advantages of these two approaches. This contemporary analysis examines national trends to assess potential differences in resource utilization metrics along with perioperative outcomes between the two approaches. Methods: We analyzed the Nationwide Inpatient Sample database for cancer patients who underwent pancreaticoduodenectomies from 2016 through 2020. We compared socio-demographics, length of stay (LOS), total charges, and perioperative complications between MIPD and OPD. Results: In this observational study, MIPD was associated with lower total charges ($97,470 vs $126,586), shorter LOS (5.05 vs 7.37 days), and lower odds of perioperative complications (OR 1.40, 95% CI 1.18-1.65) compared to OPD. While total charges increased similarly in both groups over time, a declining trend in LOS was observed for OPD (11.49 to 10.36 days). Non-white race and private/other insurance correlated with longer stays, higher charges, and more complications regardless of surgical approach. Conclusions: Despite the gradual improvements in LOS observed with OPD, MIPD demonstrated advantages in resource utilization metrics, indicating potential for reduced healthcare utilization and costs compared to the open surgical approach during the study period. Continued prospective investigation is warranted to comprehensively evaluate MIPD's value proposition.
背景:虽然历史上已经证明微创胰十二指肠切除术(MIPD)优于开放式胰十二指肠切除术(OPD),但最近围手术期护理和手术技术的进步可能影响了这两种方法的相对优势。本当代分析考察了国家趋势,以评估两种方法在资源利用指标以及围手术期结果方面的潜在差异。方法:我们分析了2016年至2020年接受胰十二指肠切除术的癌症患者的全国住院患者样本数据库。我们比较了MIPD和OPD之间的社会人口统计学、住院时间(LOS)、总费用和围手术期并发症。结果:在这项观察性研究中,与OPD相比,MIPD与较低的总费用(97,470美元对126,586美元),较短的LOS(5.05天对7.37天)和较低的围手术期并发症发生率(OR 1.40, 95% CI 1.18-1.65)相关。随着时间的推移,两组的总费用增加相似,但OPD的LOS呈下降趋势(11.49至10.36天)。非白人种族和私人/其他保险与更长的住院时间、更高的费用和更多的并发症相关,无论手术方式如何。结论:尽管通过OPD观察到LOS逐渐改善,但在研究期间,与开放手术方法相比,MIPD在资源利用指标上显示出优势,表明有可能降低医疗保健利用率和成本。持续的前瞻性调查是必要的,以全面评估MIPD的价值主张。
期刊介绍:
The American Surgeon is a monthly peer-reviewed publication published by the Southeastern Surgical Congress. Its area of concentration is clinical general surgery, as defined by the content areas of the American Board of Surgery: alimentary tract (including bariatric surgery), abdomen and its contents, breast, skin and soft tissue, endocrine system, solid organ transplantation, pediatric surgery, surgical critical care, surgical oncology (including head and neck surgery), trauma and emergency surgery, and vascular surgery.